Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Verrica Pharmaceuticals Inc. (VRCA) had Revenue of $5.86M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$5.86M
Net Income	$-13.15M
Cost of Goods Sold	$0.88M
Gross Profit	$4.98M
Operating Expenses	$18.96M
Operating Income	$-13.10M
Non-Operating Income/Expense	$-0.06M
Pre-Tax Income	$-13.15M
Normalized Pre-Tax Income	$-13.15M
Income after Taxes	$-13.15M
Income from Continuous Operations	$-13.15M
Consolidated Net Income/Loss	$-13.15M
Normalized Income after Taxes	$-13.15M
EBIT	$-13.10M
EBITDA	$-12.89M
Weighted-Average Shares Outstanding (Basic)	21.30M
Weighted-Average Shares Outstanding (Diluted)	21.30M
Earnings per Share (EPS) (Basic)	$-0.62
Earnings per Share (EPS) (Diluted)	$-0.62
Balance Sheet Financials
Current Assets	$32.64M
Property, Plant, and Equipment	$0.18M
Long-Term Assets	$3.38M
Total Assets	$36.02M
Current Liabilities	$22.44M
Long-Term Debt	$0.79M
Long-Term Liabilities	$9.27M
Total Liabilities	$31.71M
Common Equity	$4.31M
Tangible Shareholders Equity	$4.31M
Shareholders Equity	$4.31M
Common Shares Outstanding	17.18M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-18.44M
Cash Flow from Investing Activities	$0.00M
Cash Flow from Financial Activities	$-0.25M
Beginning Cash	$30.15M
End Cash	$11.46M
Increase/Decrease in Cash	$-18.69M
Stock-Based Compensation	$2.11M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.45
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.16
Debt to Equity Ratio	0.32
Gross Margin	85.02%
Operating Margin	-223.42%
EBIT Margin	-223.42%
EBITDA Margin	--
Pre-Tax Profit Margin	-224.38%
Profit Margin	-224.38%
Free Cash Flow	$-18.44M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.32
Receiveable Turnover	0.53
Days Sales in Receivables	170.27
Return on Equity	-305.38%
Return on Tangible Equity	-305.39%
Return on Assets	-36.52%
Return on Investments	-257.90%
Book Value Per Share	$0.25
Free Cash Flow per Share	$-0.87
Operating Cash Flow per Share	$-0.87

Data from Zacks Investment Research, Inc.